| Dr Katelyn Rebecca Marie Neverman, PHARMD | |
|
1025 Marsh St, Mankato, MN 56001-4752 | |
| (507) 625-4031 | |
| Not Available |
| Full Name | Dr Katelyn Rebecca Marie Neverman |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1025 Marsh St, Mankato, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023620382 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 20476-40 (Wisconsin) | Secondary |
| 183500000X | Pharmacist | 125099 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Katelyn Rebecca Marie Neverman, PHARMD 247 Mann St, Owatonna, MN 55060-3248 Ph: (507) 696-2226 | Dr Katelyn Rebecca Marie Neverman, PHARMD 1025 Marsh St, Mankato, MN 56001-4752 Ph: (507) 625-4031 |
News Archive
Takeda Pharmaceutical Company Limited ("Takeda") and Takeda Global Research & Development Center, Inc., a wholly owned United States (U.S.) subsidiary, today jointly announced that the latter has received notification that the U.S. Food and Drug Administration (FDA) has agreed to the study design for a cardiovascular (CV) outcomes trial titled EXAMINE (EXamination of CArdiovascular OutcoMes: AlogliptIN vs. Standard of CarE in Patients with Type 2 Diabetes Mellitus and Acute Coronary Syndrome) for alogliptin, a selective dipeptidyl peptidase IV inhibitor under investigation for the treatment of type 2 diabetes as an adjunct to diet and exercise.
For nearly two decades, Ivy Pike, an associate professor of anthropology at the University of Arizona, has been studying ethnic groups in rural northern Kenya to understand how violence shapes the health of those eking out a living there.
Though researchers have made substantial progress in developing drug-ferrying nanoparticles that successfully target tumor cells in living animals, including humans, investigators have only now started the detailed work needed to identify formulation parameters that would optimize drug delivery to malignant cells.
Canopus BioPharma Inc. today announces that it has completed crucial research in confirming efficacy of a prescription drug: CB008 for Ebola Virus inhibition.
The "Enough Food for Everyone If" campaign (IF campaign), "supported by a coalition of more than 100 development organizations, has identified four priorities on aid, land, tax avoidance and market transparency," Zahid Torres-Rahman, founder of Business Fights Poverty, writes in the Guardian Sustainable Business blog.
› Verified 9 days ago
Daniel Fandrich, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1270 E Madison Ave, Mankato, MN 56001 Phone: 507-388-1315 Fax: 507-388-6369 | |
Bradley Dean Borresen, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2010 Adams St, Mankato, MN 56001 Phone: 507-625-7565 | |
Jairus Matthew Mcbride, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 410 S Riverfront Dr, Mankato, MN 56001 Phone: 507-345-5091 Fax: 507-625-4735 | |
Dr. Kenneth Patrick Buckley, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1175 Madison Ave, Mankato, MN 56001 Phone: 507-625-1791 Fax: 507-625-9262 | |
Jenna Jackson, PHARM.D., R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1025 Marsh St, Mankato, MN 56001 Phone: 507-594-2999 | |
Carol Daley, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1200 S Riverfront Dr, Mankato, MN 56001 Phone: 507-345-5066 |